Literature DB >> 12207914

Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD.

Fumika Orii1, Toshifumi Ashida, Masafumi Nomura, Atsuo Maemoto, Takanori Fujiki, Tokiyoshi Ayabe, Shinjiro Imai, Yusuke Saitoh, Yutaka Kohgo.   

Abstract

We have previously reported that in peripheral blood mononuclear cells (PBMC), the augmented expression of the beta isoform of the human glucocorticoid receptor (hGRbeta), as a putative dominant negative regulator of glucocorticoid action, is associated with glucocorticoid (GC) unresponsiveness of UC patients. In this study, we quantified the levels and serial changes of hGR transcripts in PBMC of IBD patients by a real-time fluorescence monitoring of PCR. As results, relative hGRbeta mRNA expression was significantly higher in the active stage of UC than in inactive periods of UC or CD patients. Longitudinal analysis revealed that hGRbeta mRNA expression in UC was increased after the relapse of inflammation, suggesting that the overproduction of cytokines during inflammation may be responsible. In in vitro culture experiments of human lymphoid cell (CEM) and human PBMC, IL-7, and IL-18 increased hGRbeta mRNA expression in these cells but GC itself did not. Through these analyses, it is indicated that the inflammatory cytokines altered the splicing condition of the primary transcript of hGR gene in IBD patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207914     DOI: 10.1016/s0006-291x(02)02030-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

Review 1.  Minireview: live and let die: molecular effects of glucocorticoids on bone cells.

Authors:  Lorenz C Hofbauer; Martina Rauner
Journal:  Mol Endocrinol       Date:  2009-05-28

Review 2.  Glucocorticoid receptor: implications for rheumatic diseases.

Authors:  T Kino; E Charmandari; G P Chrousos
Journal:  Clin Exp Rheumatol       Date:  2011-10-21       Impact factor: 4.473

3.  High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance.

Authors:  R Towers; T Naftali; G Gabay; M Carlebach; A Klein; B Novis
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  Ex vivo stimulation of cord blood mononuclear cells by dexamethasone and interleukin-7 results in the maturation of interferon-gamma-secreting effector memory T cells.

Authors:  V Yu Talayev; I Ye Zaichenko; O N Babaykina; M A Lomunova; E B Talayeva; M F Nikonova
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

5.  Probing Dominant Negative Behavior of Glucocorticoid Receptor β through a Hybrid Structural and Biochemical Approach.

Authors:  Jungki Min; Lalith Perera; Juno M Krahn; Christine M Jewell; Andrea F Moon; John A Cidlowski; Lars C Pedersen
Journal:  Mol Cell Biol       Date:  2018-03-29       Impact factor: 4.272

Review 6.  Glucocorticosteroids: current and future directions.

Authors:  Peter J Barnes
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

7.  Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver.

Authors:  Debra C DuBois; Siddharth Sukumaran; William J Jusko; Richard R Almon
Journal:  Steroids       Date:  2012-12-19       Impact factor: 2.668

Review 8.  Naturally occurring C-terminal splice variants of nuclear receptors.

Authors:  Michiel van der Vaart; Marcel J M Schaaf
Journal:  Nucl Recept Signal       Date:  2009-06-19

9.  The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression.

Authors:  James T Lynch; Ramkumar Rajendran; Georgia Xenaki; Ilhem Berrou; Constantinos Demonacos; Marija Krstic-Demonacos
Journal:  Mol Cancer       Date:  2010-02-15       Impact factor: 27.401

Review 10.  Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology.

Authors:  Tomoshige Kino; Yan A Su; George P Chrousos
Journal:  Cell Mol Life Sci       Date:  2009-07-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.